April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Retrospective review of surgical outcome with iStent surgery
Author Affiliations & Notes
  • Ahmad Alali
    Mcgill university, Montreal, QC, Canada
    ophthalmology, Jewish General Hospital, Montreal, QC, Canada
  • Samir Jabbour
    Mcgill university, Montreal, QC, Canada
  • Hady Saheb
    Mcgill university, Montreal, QC, Canada
  • Marc Mydlarski
    Mcgill university, Montreal, QC, Canada
    ophthalmology, Jewish General Hospital, Montreal, QC, Canada
  • Footnotes
    Commercial Relationships Ahmad Alali, None; Samir Jabbour, None; Hady Saheb, None; Marc Mydlarski, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3181. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ahmad Alali, Samir Jabbour, Hady Saheb, Marc Mydlarski; Retrospective review of surgical outcome with iStent surgery. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3181.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the postoperative outcomes of the trabecular bypass micro-stent (iStent) in patients with glaucoma in a Canadian academic center.

Methods: A retrospective interventional case series involving 27 eyes that underwent iStent implantation alone or iStent implantation with concurrent cataract surgery. Both primary and secondary glaucoma cases were included. Patients were assessed preoperatively and postoperatively on day 1 and 7 and months 1, 3,and 6. Examinations included intraocular pressure (IOP), visual acuity, number of glaucoma medications and procedure-related complications.

Results: The mean age of the patients was 74.2 +/- 8.9 (range 61-93). The mean baseline IOP was 18.6 +/- 4.5 (range 10-29) and was decreased to 17.8 +/- 5.6 (P >0.05) at 1 month, to 13 +/- 4.7 at 3 months (P <0.05), and to 13.3 +/- 1.7 (P <0.05) at 6 months. The mean number of glaucoma medications at baseline was 2.6 +/- 0.9 (range 1-4) and was reduced to 1.6 +/- 1.3 at 1 month (P <0.05), 1.7 +/- 1.5 at 3 months (P < 0.05) and 2.25 + 1.5 at 6 months (P >0.05). Postoperative adverse events included IOP spike (raise in IOP > 10mmHg from pre-op baseline) in 13 eyes, mild hyphema in 1 eye, and blockage of the iStent in 3 eyes. Three patients required subsequent glaucoma surgery.

Conclusions: Combined iStent implantation and cataract surgery lead to a significant reduction in IOP and medication use in a Canadian academic center.

Keywords: 568 intraocular pressure • 421 anterior segment  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×